15 September 1986
7 April 1986
COMMERCIAL ITEM DESCRIPTION
POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-B-37201 which is cancelled.
Shall be Potassium Chloride Extended-Release Tablets, USP.
Shall be in accordance with the requirements of the USP.
For Strength 1, shall be extended-release tablets containing 600 mg of Potassium Chloride, equivalent to 8 mEq of potassium per tablet within the applicable assay limits.
The tablets must be considered by the FDA to be therapeutically equivalent with Potassium Chloride Tablets Controlled Release by Ciba-Geigy at the same dosage and administration schedule.
For Strength 2, shall be extended-release, wax matrix, film coated tablets containing 750 mg of Potassium Chloride (equivalent to 10 mEq each of potassium and chloride) within the applicable assay limits.
Workmanship. Tablets shall be free from defects which detract from their appearance or impair their serviceability.
For Size 1, Bottle (BT). One bottle containing 100 tablets, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business